Patterns of Structural Recurrence in Papillary Thyroid Cancer

[1]  Chieh-Hsi Wu,et al.  A population‐based nested case–control study: the use of 5‐alpha‐reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia , 2015, Clinical endocrinology.

[2]  P. Ituarte,et al.  Effect of reoperation on outcomes in papillary thyroid cancer. , 2013, Surgery.

[3]  A. Gill,et al.  Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma. , 2013, Surgery.

[4]  S. Roman,et al.  Central lymph node dissection in patients with papillary thyroid cancer: a population level analysis of 14,257 cases. , 2013, American journal of surgery.

[5]  M. Schlumberger,et al.  Influence of Prophylactic Neck Dissection on Rate of Retreatment for Papillary Thyroid Carcinoma , 2013, World Journal of Surgery.

[6]  Shuangge Ma,et al.  The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. , 2013, Thyroid : official journal of the American Thyroid Association.

[7]  M. Schlumberger,et al.  Strategies of radioiodine ablation in patients with low-risk thyroid cancer. , 2012, The New England journal of medicine.

[8]  A. Sterpetti.  Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. , 2012, Annals of surgery.

[9]  E. Baudin,et al.  Optimization of Staging of the Neck With Prophylactic Central and Lateral Neck Dissection for Papillary Thyroid Carcinoma , 2012, Annals of surgery.

[10]  F. Emma,et al.  Eculizumab for the treatment of dense-deposit disease. , 2012, The New England journal of medicine.

[11]  Kevin Ro,et al.  A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. , 2011, Surgery.

[12]  Byung-Joo Lee,et al.  Lateral cervical lymph node metastases from papillary thyroid carcinoma: predictive factors of nodal metastasis. , 2011, Surgery.

[13]  T. Fahey,et al.  Prophylactic Central Neck Dissection and Local Recurrence in Papillary Thyroid Cancer: A Meta-analysis , 2010, Annals of Surgical Oncology.

[14]  T. Fahey,et al.  Impact of Prophylactic Central Neck Lymph Node Dissection on Early Recurrence in Papillary Thyroid Carcinoma , 2010, World Journal of Surgery.

[15]  S. Falkmer,et al.  Differentiated thyroid cancer in a Swedish county – long-term results and quality of life , 2010, Acta oncologica.

[16]  H. Boztepe,et al.  The long term outcome of papillary thyroid carcinoma patients without primary central lymph node dissection: expected improvement of routine dissection. , 2009, Surgery.

[17]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[18]  Jin Young Kwak,et al.  Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT. , 2009, AJR. American journal of roentgenology.

[19]  J. Roh,et al.  Prevention of postoperative hypocalcemia with routine oral calcium and vitamin D supplements in patients with differentiated papillary thyroid carcinoma undergoing total thyroidectomy plus central neck dissection , 2009, Cancer.

[20]  V. Zaydfudim,et al.  The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. , 2008, Surgery.

[21]  G. Pentheroudakis,et al.  Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  J. Tward,et al.  The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. , 2008, The Journal of clinical endocrinology and metabolism.

[23]  S. Sidhu,et al.  ROUTINE LEVEL VI LYMPH NODE DISSECTION FOR PAPILLARY THYROID CANCER: SURGICAL TECHNIQUE , 2007, ANZ journal of surgery.

[24]  G. Doherty,et al.  Central Lymph Node Dissection in Differentiated Thyroid Cancer , 2007, World Journal of Surgery.

[25]  A. Shaha.  TNM Classification of Thyroid Carcinoma , 2007, World journal of surgery.

[26]  S. Sidhu,et al.  Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. , 2006, Surgery.

[27]  Louise Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.

[28]  Q. Duh,et al.  Selective Modified Radical Neck Dissection for Papillary Thyroid Cancer—Is Level I, II and V Dissection Always Necessary? , 2006, World Journal of Surgery.

[29]  P. Hall,et al.  Clinically significant prognostic factors for differentiated thyroid carcinoma , 2006, Cancer.

[30]  Bruno D Fornage,et al.  Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. , 2003, Surgery.

[31]  T. Defechereux,et al.  Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma , 1998, Langenbeck's Archives of Surgery.

[32]  H. Hundeshagen,et al.  Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer , 1994, World Journal of Surgery.

[33]  R. Hinze,et al.  Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer , 2001, World Journal of Surgery.